📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Using DNA sequencing data to quantify T cell fraction and therapy response. (2021)

First Author: Bentham R

Attributed to: Lethal renal cell carcinoma sub-clones: Defining mechanisms of tumour evolution, treatment resistance and immune escape. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41586-021-03894-5

PubMed Identifier: 34497419

Publication URI: http://europepmc.org/abstract/MED/34497419

Type: Journal Article/Review

Volume: 597

Parent Publication: Nature

Issue: 7877

ISSN: 0028-0836